✦ LIBER ✦

Experience in the Treatment of Cutaneous In-Transit Melanoma Metastases and Satellitosis With Intralesional Interleukin-2

✍ Scribed by L.A. Dehesa; J. Vilar-Alejo; P. Valerón-Almazán; G. Carretero

Book ID: 119628052
Publisher: Elsevier Science
Year: 2009
Tongue: Spanish
Weight: 410 KB
Volume: 100
Category: Article
ISSN: 0001-7310
DOI: 10.1016/s1578-2190(09)70125-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of intralesional therapy

Phase II trial of intralesional therapy with interleukin-2 in soft-tissue melanoma metastases

✍ Radny, P; Caroli, U M; Bauer, J; Paul, T; Schlegel, C; Eigentler, T K; Weide, B; 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 301 KB

Isolation perfusion in extracorporeal ci

Isolation perfusion in extracorporeal circulation with interleukin-2 and lymphokine-activated killer cells in the treatment of in-transit metastases from limb cutaneous melanoma

✍ Maurizio Vaglini; Filiberto Belli; Mario Santinami; Flavio Arienti; Giorgio Parm 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Phase I/II study of topical imiquimod an

Phase I/II study of topical imiquimod and intralesional interleukin-2 in the treatment of accessible metastases in malignant melanoma

✍ D.S. Green; M.D. Bodman-Smith; A.G. Dalgleish; M.D. Fischer 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 275 KB

Intra-lesional interleukin-2 for the tre

Intra-lesional interleukin-2 for the treatment of in-transit melanoma

✍ Kirsty U. Boyd; Bret M. Wehrli; Claire L.F. Temple 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 434 KB

Hyperthermic antiblastic perfusion in th

Hyperthermic antiblastic perfusion in the treatment of local recurrence or “In-transit” metastases of limb melanoma

✍ Renato Cavaliere; Franco Di Filippo; Diana Giannarelli; Sandro Carlini; Michele 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 570 KB

## Abstract On the basis of personal experience and a review of the literature, the authors have evaluated the results obtained with hyperthermic antiblastic perfusion (HAP) for the treatment of stage II, III and IIIAB limb melanoma. The evaluation showed that today HAP may be considered a safe an

Low-dose inhalation of interleukin-2 bio

Low-dose inhalation of interleukin-2 bio-chemotherapy for the treatment of pulmonary metastases in melanoma patients

✍ Posch, C; Weihsengruber, F; Bartsch, K; Feichtenschlager, V; Sanlorenzo, M; Vuji 📂 Article 📅 2014 🏛 Nature Publishing Group 🌐 English ⚖ 351 KB